In the US, a candidate becomes president not by winning a majority of the national popular vote, but through a system called ...

Cellectis is confident about the continued progress of its ongoing clinical trials in hematological malignancies and is ...

The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the ...

Q2 2025 Earnings Conference Call October 31, 2024 2:30 AM ET. Company Participants. Hiroyuki Okuzawa - Representative Director, Presi ...

Quell Therapeutics Ltd (“Quell”), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces that management will ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Microsoft exceeded expectations in the first fiscal quarter with earnings per share of $3.30 (above the expected $3.10) and ...

AstraZeneca’s corporate headquarters were chosen to be in London, United Kingdom, while its R&D headquarters were to be in Sweden, with major centres of excellence in the UK and USA.

TOKYO, Japan & BASKING RIDGE, NJ, USA I October 30, 2024 I The first patients have been dosed in three global, randomized phase 3 trials evaluating the ...

The global Cardiogenic Shock Treatment Market is expected to achieve a valuation of approximately US$ 0.9 billion in 2023, ...

The growth of the Pediatric Obesity Management Market can be attributed to the alarming rise in childhood obesity rates ...